BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matsumoto T, Itoh S, Yoshizumi T, Kurihara T, Yoshiya S, Mano Y, Takeishi K, Harada N, Ikegami T, Soejima Y, Baba H, Mori M. C-reactive protein : albumin ratio in patients with resectable intrahepatic cholangiocarcinoma. BJS Open 2020. [PMID: 32959537 DOI: 10.1002/bjs5.50348] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Lang SA, Bednarsch J, Joechle K, Amygdalos I, Czigany Z, Heij L, Ulmer TF, Neumann UP. Prognostic biomarkers for cholangiocarcinoma (CCA): state of the art. Expert Rev Gastroenterol Hepatol 2021;15:497-510. [PMID: 33970740 DOI: 10.1080/17474124.2021.1912591] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 He C, Zhao C, Zhang Y, Chen C, Lin X. An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection. J Inflamm Res 2021;14:1859-72. [PMID: 34012285 DOI: 10.2147/JIR.S311084] [Reference Citation Analysis]
3 Frey A, Martin D, D’cruz L, Fokas E, Rödel C, Fleischmann M. C-Reactive Protein to Albumin Ratio as Prognostic Marker in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy. Biomedicines 2022;10:598. [DOI: 10.3390/biomedicines10030598] [Reference Citation Analysis]
4 Toshida K, Itoh S, Yoshizumi T, Shimagaki T, Wang H, Kurihara T, Toshima T, Nagao Y, Harada N, Oki E, Nakamura Y, Yoshino T, Mori M. Efficacy of pembrolizumab in microsatellite instability-high locally advanced cholangiocarcinoma: a case report. Clin J Gastroenterol 2021. [PMID: 34085164 DOI: 10.1007/s12328-021-01458-8] [Reference Citation Analysis]